Floatz logo

cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr

Recurrent Acute Undifferentiated Leukemia

Fred Hutchinson Cancer CenterCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

32 Active assets in the Recurrent Acute Undifferentiated Leukemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Fred Hutchinson Cancer Center
Phase 2BB
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 3BB
METHOTREXATE
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BB
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 3BB
DEXAMETHASONE
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BB

View all 50 →

Same molecule, other indications

cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr is also rated in:

acute biphenotypic leukemiaDormant
CC
Indicative ·
43 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
CC
Indicative ·
43 / 100
View asset →
juvenile myelomonocytic leukemiaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →